(Q44758863)

6 December 2017

title

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant (English)

1 reference

6 December 2017

0 references

1 reference

5

van Rhee F

1 reference

6 December 2017

Lee CK

1

1 reference

6 December 2017

Zangari M

2

1 reference

6 December 2017

Barlogie B

3

1 reference

6 December 2017

Fassas A

4

1 reference

6 December 2017

Thertulien R

6

1 reference

6 December 2017

Talamo G

7

1 reference

6 December 2017

Muwalla F

8

1 reference

6 December 2017

Anaissie E

9

1 reference

6 December 2017

Hollmig K

10

1 reference

6 December 2017

Tricot G

11

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

Bone Marrow Transplantation

6 December 2017

published in

1 reference

6 December 2017

volume

33

1 reference

6 December 2017

issue

8

1 reference

6 December 2017

page(s)

823-828

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704440

6 December 2017

exact match

0 references

cites work

Results of autologous stem cell transplant in multiple myeloma patients with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

DTPACE: an effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

Cytotoxic chemotherapy following tandem autotransplants in multiple myeloma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

Extended survival in advanced and refractory multiple myeloma after single-agent thalidomide: identification of prognostic factors in a phase 2 study of 169 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

Renal Failure in Multiple Myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

7 January 2021

Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

7 January 2021

Renal function recovery in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

7 January 2021

Disappearance of nodular mesangial lesions in a patient with light chain nephropathy after long-term chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

7 January 2021

Patients with multiple myeloma requiring long-term dialysis: presenting features, response to therapy, and outcome in a series of 20 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704440

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704440

1 reference

Dimensions Publication ID

6 December 2017

1021997370

0 references

1 reference